Kinase inhibitor drugs

A tyrosine kinase inhibitor (TKI) is a pharmaceutical drug that inhibits tyrosine kinases. Tyrosine kinases are enzymes responsible for the activation of

Immunosuppressive Drugs for Ulcerative Colitis. Tofacitinib is a type of immunosuppressant called a Janus kinase inhibitor (JAK inhibitor). It works by blocking Janus kinase, which is an

Sorafenib and lenvatinib are types of drugs called tyrosine kinase inhibitors (TKIs), or multi-kinase inhibitors. They work by blocking (inhibiting) signals in

by KL Keller 2024 Cited by 39Tyrosine kinase inhibitors are increasingly used in the treatment of cancer. Drug interactions involving tyrosine kinase inhibitors are

There are drugs that can block tyrosine kinase cellular activity. These drugs are called tyrosine kinase inhibitors or TKIs. The theory behind

Protein kinase inhibitors are drugs that can inhibit the action of protein kinases. Protein kinases add a phosphate group to a protein to switch it on or off.

Outline the different types of tyrosine kinase inhibitor (TKI) drugs and the currently available TKIs. Describe the mechanism of action of tyrosine kinase inhibitors. Summarize the indications and contraindications for each type of tyrosine kinase inhibitor.

This group of drugs are called tyrosine kinase inhibitors. The tyrosine kinase inhibitors used to treat kidney cancer are: axitinib

A tyrosine kinase inhibitor (TKI) is a pharmaceutical drug that inhibits tyrosine kinases. Development of drugs. edit. Numerous TKIs aiming at various